LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $349,000 | -28.6% | 3,000 | 0.0% | 0.03% | +7.1% |
| Q4 2021 | $489,000 | +16.4% | 3,000 | 0.0% | 0.03% | +33.3% |
| Q3 2021 | $420,000 | +3.7% | 3,000 | 0.0% | 0.02% | -12.5% |
| Q2 2021 | $405,000 | -9.4% | 3,000 | 0.0% | 0.02% | -31.4% |
| Q1 2021 | $447,000 | +51.0% | 3,000 | 0.0% | 0.04% | +84.2% |
| Q4 2020 | $296,000 | +3.1% | 3,000 | 0.0% | 0.02% | -24.0% |
| Q3 2020 | $287,000 | -15.3% | 3,000 | 0.0% | 0.02% | -24.2% |
| Q2 2020 | $339,000 | +58.4% | 3,000 | 0.0% | 0.03% | +57.1% |
| Q1 2020 | $214,000 | -33.3% | 3,000 | 0.0% | 0.02% | -22.2% |
| Q4 2019 | $321,000 | +8.1% | 3,000 | 0.0% | 0.03% | -18.2% |
| Q3 2019 | $297,000 | -13.2% | 3,000 | 0.0% | 0.03% | +43.5% |
| Q2 2019 | $342,000 | -7.8% | 3,000 | 0.0% | 0.02% | -4.2% |
| Q1 2019 | $371,000 | -9.7% | 3,000 | 0.0% | 0.02% | -4.0% |
| Q4 2018 | $411,000 | -50.0% | 3,000 | 0.0% | 0.02% | -35.9% |
| Q3 2018 | $822,000 | – | 3,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |